Kiora Pharmaceuticals, Inc.

Kiora Pharmaceuticals, an American pharmaceutical company, targets critical pathways underlying vision-threatening retinal diseases using innovative small molecules to slow, stop, or restore vision loss for conditions with limited or no effective therapies; it is headquartered in Waltham, United States.

Here are key aspects of the company:

• Products & Services: The firm develops innovative small molecules designed to address critical pathways in vision-threatening retinal diseases.
• Industries: Kiora focuses on the pharmaceutical sector with a specific emphasis on treating conditions that currently lack effective therapies.
• Innovation: The company utilizes novel molecular approaches aimed at slowing, stopping, or restoring vision loss for patients suffering from severe eye disorders.

Kiora Pharmaceuticals is dedicated to advancing treatments for retinal diseases through its specialized focus on innovative small molecule therapeutics.